Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$2.85 USD
-0.02 (-0.70%)
Updated Aug 28, 2025 04:00 PM ET
After-Market: $2.85 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Black Diamond Therapeutics, Inc. has a market cap of $163.40M, which represents its share price of $2.87 multiplied by its outstanding shares number of 56.94M. As a small-cap company, BDTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BDTX 2.85 -0.02(-0.70%)
Will BDTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BDTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BDTX
Black Diamond (BDTX) Upgraded to Strong Buy: Here's Why
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year?
BDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know
Other News for BDTX
BDTX forms NR7 on August 27
BDTX rises 1.05% on August 26, leaving the technical picture intact
Black Diamond Therapeutics: A Potential First-Line In NSCLC Trading At Cash
BDTX forms Stochastic Reached Overbought on August 25
Is BDTX building bullish momentum? MACD Bullish Centerline Cross shows up after surging 7.75%